PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11999992

Nitrification utilizing CaCO3 as the buffering agent.

M Green·Y Ruskol·S Tarre·R E Loewenthal
View original source ↗Export metadata ↓

Abstract

Nitrification utilizing chalk (calcium carbonate) as the buffering agent was investigated. Three different fluidized bed reactor configurations were examined in order to study the effect of reactor layout on nitrification and concomitant chalk dissolution. The first system consisted of two interconnected columns with high recycle rate, one containing zeolite as the carrier for the nitrifying biomass and the other chalk as the buffering agent. The second reactor system consisted of a single column containing both zeolite and chalk particles. In the third system, nitrification was carried out in a single column where chalk particles were used both as the carrier for the biomass and as the buffer. Results showed that only the reactor with chalk acting as both the buffering agent and the biomass carrier could be operated without external buffer (NaHCO3) addition. This system operated at high ammonium removal rates of up to 2.5 g N l(-1) reactor d(-1) even though the bulk solution of the reactor had a low pH of 5.5. The high nitrification efficiency at this low pH was probably mainly a result of a favorable microenvironment surrounding the nitrifying biomass attached to the chalk.

Explore related subjects

AntacidsCalcium CarbonateHydrogen-Ion ConcentrationNitrogenOxidation-ReductionQuaternary Ammonium CompoundsTemperatureWaste Disposal, FluidJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Green, Y Ruskol, S Tarre, R E Loewenthal. 2002. Nitrification utilizing CaCO3 as the buffering agent.. https://doi.org/10.1080/09593332508618410

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

[On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].

Gastric acid inhibitors are effective and safe drugs for the treatment of gastro-oesophageal reflux disease. Since reflux disease is frequent in Western populations, the use of gastric acid inhibitors leads to a considerable financial burden to the community. However, a large proportion of the patients with reflux symptoms do not take their medication continuously but use the drugs as required by their symptoms. This opens the possibility of a more cost-effective approach in which optimal symptom relief is achieved in combination with cost reduction. The type of on-demand therapy must be based on the individual pattern of reflux symptoms. In this approach, the patient determines the actual therapy whereas the physician functions as advisor. It is presently unknown whether any adverse effects result from the long-term on-demand therapy of reflux disease.

Antacids↗
PubMed2003

[As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].

Although proton pump inhibitors and H2-receptor antagonists are usually prescribed for continuous use by patients with gastro-oesophageal reflux disease, at least 50% of such patients do not take their medication daily and some take it only sporadically. On-demand treatment with proton pump inhibitors or H2-receptor antagonists is safe and cost-effective. Indications are: (a) incidental reflux episodes of short duration, (b) periodic reflux lasting several weeks or months, (c) chronic reflux not requiring continuous treatment. On-demand treatment is unsuitable for patients with reflux disease who either require daily medication or in whom the maximal dosage is insufficient. There are three types of on-demand treatment. Type 1: use of medication only in case of incidental symptoms. Type 2: continuous medication for 2-4 weeks when symptoms appear. Type 3: continuous use because of chronic symptoms, but the interval between doses is determined by the patient on the basis of his symptoms. All antacids can in principle be used for on-demand treatment; for type 3 treatment, antacids with a rapid onset of action are preferred. A favourable response to the two weeks of initial therapy is a good predictor for successful on-demand treatment.

Antacids↗